Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety and Immunogenicity of MEDI3414 (H1N1 LAIV) in Children
NCT00946101Phase 4Completed
- Sponsor
- MedImmune
- Start
- Aug 2009
- Primary completion
- Sep 2009
- Modality
- Live Attenuated Vaccines
- Countries
- 1
01
Overview
A Phase 4 trial of MEDI3414 in influenza A H1N1 infection (H1N1), sponsored by MedImmune. Started Aug 2009; status: completed.
02
Drugs
MEDI3414
03
Conditions
influenza A H1N1 infection (H1N1)
Beyond the preview
Go deeper on NCT00946101.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00946101.